146 related articles for article (PubMed ID: 22739081)
1. Does direct inhibition bring direct benefit?
Abe S; Taguchi I; Inoue T
Circ J; 2012; 76(6):1326. PubMed ID: 22739081
[No Abstract] [Full Text] [Related]
2. Effect of direct renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction.
Ozaki Y; Imanishi T; Tanimoto T; Kashiwagi M; Tsujioka H; Sougawa H; Orii M; Shiono Y; Shimamura K; Ishibashi K; Komukai K; Ino Y; Kitabata H; Akasaka T
Circ J; 2012; 76(6):1461-8. PubMed ID: 22453004
[TBL] [Abstract][Full Text] [Related]
3. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy: inhibiting LV remodeling—the need for a targeted approach.
Cohn JN
Nat Rev Cardiol; 2011 May; 8(5):248-9. PubMed ID: 21448137
[No Abstract] [Full Text] [Related]
5. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
6. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Middeke M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
[No Abstract] [Full Text] [Related]
7. Renin inhibition: the holy grail of renin-angiotensin system blockade?
McInnes GT
J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
[No Abstract] [Full Text] [Related]
8. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
9. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
Schleich F; Krzesinski JM; Piérard L; Scheen AJ
Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
[TBL] [Abstract][Full Text] [Related]
10. [spACE, the last frontier? Renin inhibition in hypertension].
Villa L
G Ital Nefrol; 2008; 25(3):274. PubMed ID: 18473295
[No Abstract] [Full Text] [Related]
11. Aliskiren and dual therapy in type 2 diabetes mellitus.
Ingelfinger JR
N Engl J Med; 2008 Jun; 358(23):2503-5. PubMed ID: 18525047
[No Abstract] [Full Text] [Related]
12. Aliskiren combined with losartan in diabetes and nephropathy.
Lindner T
N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
[No Abstract] [Full Text] [Related]
13. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
Ram CV
Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren combined with losartan in diabetes and nephropathy.
Anderson S; Komers R
N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
[No Abstract] [Full Text] [Related]
16. Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context.
Krum H; Maggioni A
Clin Cardiol; 2010 Sep; 33(9):536-41. PubMed ID: 20842736
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
18. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D
Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]